Patients with a greater than 10 pack/year history of smoking tend to develop an especially dangerous form of head and neck squamous cell cancer (HNSCC) for which prognosis remains poor and treatments have changed little during ...
6
0
A critical biomarker of kidney disease may help predict clear cell kidney cancer—the most common form of kidney cancer—years before clinical diagnosis. Kidney-injury-molecule-1 (KIM-1) can be detected in the urine and ...
4
0
New-generation lung cancer drugs have been effective in a large number of patients, but within about a year, the patients tend to develop resistance to the therapy. Researchers at the Weizmann Institute of Science, in collaboration ...
1
0
Inflammation and evasion of the immune system have been reported to be some of the new hallmarks of cancer. Notably, a high-fat diet (HFD) causes obesity and chronic inflammation, and studies conducted on mice have shown ...
13
0
Scientists have developed a new test to identify patients who are at risk of suffering a relapse from testicular cancer.
7
0
A new gene test can identify which patients are likely to suffer more aggressive forms of the childhood cancer rhabdomyosarcoma, new research reports.
25
0
UK-funded scientists have developed a blood test that could help pair cancer patients with the most suitable therapy for their disease and then track the tumour's progress to see if the treatment is working, according to ...
11
1
A new treatment for melanoma could be on the horizon, thanks to a finding by a UNC Lineberger Comprehensive Cancer Center-led team. In the study, which was published online today in the journal Clinical Cancer Research, the ...
162
0
Recent data suggest that epigenetic therapies are likely to provide additional clinical benefit to cancer patients when rationally combined with immunotherapeutic drugs, according to a review published in Clinical Cancer ...
21
0
MEHD7945A, a dual-action antibody that targets two members of the epidermal growth factor receptor (EGFR) family, was found to be safe and showed clinical activity in some patients with locally advanced or metastatic refractory ...
8
0
